Total Credits: .75 including .75 AOA Category 1-A Credit(s), .75 AMA PRA Category 1 Credit(s)™
Valley Fever (Coccidioidomycosis): Dealing with it now and preventing it in the future
John Galgiani, MD
Learning Objectives:
Dr. Galgiani has no disclosures.
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of .75 hours of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Accreditation Requirements and ACCME Accreditation Requirements. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.
| Valley Fever (Coccidioidomycosis): Dealing with it now and preventing it in the future (6.9 MB) | 23 Pages | Available after Purchase |
Dr. Galgiani received his medical degree from Northwestern Medical School, completed a fellowship in Infectious Diseases at Stanford and has been on the faculty of the University of Arizona since 1978. He has focused his career on the special problem of coccidioidomycosis, also known as Valley fever, including studies of the impact of Valley fever on the general population and on special groups such as organ transplant recipients and patients with AIDS. He is the lead author on the Infectious Diseases Society of America’s practice guidelines for coccidioidomycosis. In 1996, Dr. Galgiani founded the Valley Fever Center for Excellence. In collaboration with Banner Health, Dr. Galgiani developed and is now implementing a training program for primary care clinicians for prompt recognition and optimal management of patients with new Valley fever infections. The Center’s research has recently developed a vaccine candidate to prevent Valley fever in dogs and potentially in humans.